首页> 外文期刊>ACS applied materials & interfaces >Tumor-Homing and Penetrating Peptide-Functionalized Photosensitizer-Conjugated PEG-PLA Nanoparticles for Chemo-Photodynamic Combination Therapy of Drug-Resistant Cancer
【24h】

Tumor-Homing and Penetrating Peptide-Functionalized Photosensitizer-Conjugated PEG-PLA Nanoparticles for Chemo-Photodynamic Combination Therapy of Drug-Resistant Cancer

机译:肿瘤归巢和穿透肽功能化光敏剂结合的PEG-PLA纳米粒子用于耐药性药物的化学光动力学联合治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

The combination of photodynamic therapy (PDT) and chemotherapy holds great potential in combating drug-resistant cancers. However, the major challenge that lies ahead is how to achieve high coloading capacity for both photosensitizer and chemo-drugs and how to gain efficient delivery of drugs to the drug-resistant tumors. In this study, we prepared a nanovehicle for codelivery of photosensitizer (pyropheophorbide-a, PPa) and chemo-drugs (paclitaxel, PTX) based on the synthesis of PPa-conjugated amphiphilic copolymer PPa-PLA-PEG-PLA-PPa. The obtained nano particles (PP NP) exhibited a satisfactory high drug-loading capacity for both drugs. To achieve effective tumor-targeting therapy, the surface of PP NP was decorated with a tumor homing and penetrating peptide F3. In vitro cellular experiments showed that F3-functionalized PP NP (F3-PP NP) exhibited higher cellular association than PP NP and resulted in the strongest antiproliferation effect. In addition, compared with the unmodified nanoparticles, F3-PP NP exhibited a more preferential enrichment at the tumor site. Pharmacodynamics evaluation in vivo demonstrated that a longer survival time was achieved by the tumor-bearing mice treated with PP NP (+laser) than those treated with chemotherapy only or PDT only. Such antitumor efficacy of combination therapy was further improved following the F3 peptide functionalization. Collectively, these results suggested that targeted combination therapy may pave a promising way for the therapy of drug-resistant tumor.
机译:光动力疗法(PDT)和化学疗法的结合在抗药性癌症方面具有巨大潜力。然而,摆在面前的主要挑战是如何实现光敏剂和化学药物的高共负载能力,以及如何有效地将药物递送至耐药性肿瘤。在这项研究中,我们基于PPA共轭两亲共聚物PPa-PLA-PEG-PLA-PPa的合成,制备了用于光敏剂(焦脱镁叶绿素a,PPa)和化学药物(紫杉醇,PTX)的代码传递的纳米载体。所获得的纳米颗粒(PP NP)对两种药物均表现出令人满意的高载药量。为了实现有效的肿瘤靶向治疗,PP NP的表面装饰有肿瘤归巢和穿透肽F3。体外细胞实验表明,F3功能化的PP NP(F3-PP NP)表现出比PP NP更高的细胞缔合力,并具有最强的抗增殖作用。此外,与未修饰的纳米颗粒相比,F3-PP NP在肿瘤部位表现出更优先的富集。体内药效学评估表明,与仅使用化学疗法或仅使用PDT进行治疗的小鼠相比,用PP NP(+激光)治疗的荷瘤小鼠获得了更长的生存时间。 F3肽功能化后,联合治疗的这种抗肿瘤功效得到了进一步提高。总体而言,这些结果表明靶向联合治疗可能为耐药性肿瘤的治疗铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号